Cargando…
Role of Trientine in Hypertrophic Cardiomyopathy: A Review of Mechanistic Aspects
Abnormality in myocardial copper homeostasis is believed to contribute to the development of cardiomyopathy. Trientine, a copper-chelating drug used in the management of patients with Wilson’s disease, demonstrates beneficial effects in patients with hypertrophic cardiomyopathy. This review aims to...
Autores principales: | Ramli, Fitri Fareez, Hashim, Syed Alhafiz Syed, Raman, Betty, Mahmod, Masliza, Kamisah, Yusof |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9505553/ https://www.ncbi.nlm.nih.gov/pubmed/36145368 http://dx.doi.org/10.3390/ph15091145 |
Ejemplares similares
-
Reduction in Absolute Neutrophil Counts in Patient on Clozapine Infected with COVID-19
por: Ramli, Fitri Fareez, et al.
Publicado: (2021) -
Rationale and design of a randomised trial of trientine in patients with hypertrophic cardiomyopathy
por: Farrant, John, et al.
Publicado: (2023) -
The Health Argument of Climate Action during COP26: Commentaries on Mental Health Issues
por: Ramli, Fitri Fareez, et al.
Publicado: (2023) -
Factors Associated with Low Bone Density in Opioid Substitution Therapy Patients: A Systematic Review
por: Ramli, Fitri Fareez, et al.
Publicado: (2021) -
Treatments of Sexual Dysfunction in Opioid Substitution Therapy Patients: A Systematic Review and Meta-Analysis
por: Ramli, Fitri Fareez, et al.
Publicado: (2021)